ClinicalTrials.Veeva

Menu

Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System

Ascensia Diabetes Care logo

Ascensia Diabetes Care

Status

Completed

Conditions

Diabetes

Treatments

Device: Karajishi Contour Investigational BG Monitoring System

Study type

Interventional

Funder types

Industry

Identifiers

NCT02041286
GCA-2013-001-01

Details and patient eligibility

About

The purpose of this study is to determine if subjects who have diabetes can operate the Investigational Blood Glucose Monitoring System (BGMS) without training and obtain valid glucose results.

Enrollment

136 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Males and females, 18 years of age and older
  • People with type 1 or type 2 diabetes
  • Able to speak, read, and understand English
  • Willing to complete all study procedures

Exclusion criteria

  • Hemophilia or any other bleeding disorder
  • Pregnancy
  • Physical, visual, or neurological impairments that would make the person unable to perform testing with the BGM
  • Previously participated in a BG monitor study using the Karajishi BGMS (or used a Bayer Contour meter)
  • Working for a medical laboratory, hospital, or other clinical setting that involves training on and clinical use of blood glucose monitors
  • Working for a competitive medical device company, or having an immediate family member who works for such a company
  • A condition which, in the opinion of the investigator or designee, would put the person or study conduct at risk

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

136 participants in 1 patient group

Intended Users of the Monitoring System
Experimental group
Description:
Subjects with diabetes use the Karajishi Contour Investigational BG Monitoring System with no training. The criteria for the intended use population: 1. At least 60% of subjects will be younger than age 65 2. At least 10% of subjects will have type 1 diabetes
Treatment:
Device: Karajishi Contour Investigational BG Monitoring System

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems